Breakthrough Quit-Smoking Methods Unveiled: What Works and What's Missing, According to New Cochrane Reviews. Study: Effects of interventions to combat tobacco addiction: Cochrane update of 2021 to 2023 reviews . Image Credit: Josep Suria/Shutterstock.
com In a recent study published in the Addiction , a group of researchers summarized Cochrane Tobacco Addiction Group (CTAG) systematic reviews published from 2021 to 2023, highlighting key findings on effective smoking cessation interventions and identifying areas for future research. Background Tobacco smoking is a leading cause of preventable death, responsible for over 8 million deaths annually, and a major contributor to health inequalities. Quitting smoking significantly improves health and reduces the risk of disease and death.
Evidence-based support for cessation and prevention is critical for healthcare providers and policymakers. Cochrane, a not-for-profit organization, produces systematic reviews to support informed healthcare decisions. The CTAG focused on smoking cessation interventions until March 2023.
Further research is needed to refine existing interventions, explore emerging therapies, and address gaps in understanding to enhance the effectiveness of tobacco addiction treatment and prevention strategies. About the study The present article provides detailed information on abstinence and harms. These comparisons include effect estimates, number of contributing studies, sample size, the cer.
